Adaptimmune Therapeutics PLC (ADAPY): Cost of Revenue
Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$70.0K
Year ended 2024-12-31
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $70.0K | n/a | 2025-03-24, From 2024-01-01 |